As of 4:00pm ET
| -0.56 / -0.52%|
The 4 analysts offering 12-month price forecasts for Bio-Techne Corp have a median target of 115.50, with a high estimate of 118.00 and a low estimate of 102.00. The median estimate represents a +8.32% increase from the last price of 106.63.
The current consensus among 5 polled investment analysts is to Buy stock in Bio-Techne Corp. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.